← Stock Trading Canary · All insider profiles
INSIDER PROFILE · ES
ROSA MARÍA SÁNCHEZ-YEBRA ALONSO
Persona con Responsabilidad de Dirección
Profile key: es|rosa maría sánchez-yebra alonso
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 1
- Purchases · 24M
- 16
- Average purchase
- €10,054
- Gross purchase value
- €160,871
- Last purchase
- 2025-10-23
- Completed 20D events
- 8.0
- Outcome status
- PASS
Latest company: PHARMA MAR, S.A.
Companies: PHARMA MAR, S.A.
Post-purchase outcomes
Benchmark-relative outcomes are available against IBEX 35.
- Excess return = stock return − IBEX 35 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 8Developing | 100.0% (8/8) | 50.0% (4/8) | -1.2% | -0.0% | -8.2% |
| 20D | 8Developing | 100.0% (8/8) | 25.0% (2/8) | -2.2% | -1.0% | -12.4% |
| 60D | 8Developing | 100.0% (8/8) | 37.5% (3/8) | -4.3% | -3.0% | -15.1% |
| 120D | 8Developing | 100.0% (8/8) | 25.0% (2/8) | -15.5% | -11.9% | -29.1% |
Research patterns
- First purchase in 12M
- 0/7
- Large purchase ≥ €100k
- 1/8
- Cluster buying · 15D
- 4/8
- Buying the dip · ≥20% below prior 52W high
- 4/8
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.